Skip to main content
Erschienen in:

01.06.2019 | Case report

Antineoplastics

Immune-related cholangitis: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Fouchard M, et al. Three cases of immune cholangitis related to anti-programmed cell death and programmed cell death ligand agents for the treatment of non-small cell lung cancer. European Journal of Cancer 115: 107-110, Jul 2019. Available from: URL: http://doi.org/10.1016/j.ejca.2019.04.022 - France Fouchard M, et al. Three cases of immune cholangitis related to anti-programmed cell death and programmed cell death ligand agents for the treatment of non-small cell lung cancer. European Journal of Cancer 115: 107-110, Jul 2019. Available from: URL: http://​doi.​org/​10.​1016/​j.​ejca.​2019.​04.​022 - France
Metadaten
Titel
Antineoplastics
Immune-related cholangitis: 3 case reports
Publikationsdatum
01.06.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-63922-0